文献速递姑息放疗与转移瘤放疗物理与技术

糖尿病增加脊柱再照射后严重不良事件风险

Diabetes increases the risk of serious adverse events after re-irradiation of the spine.
PubMed 文献 · Radiother Oncol · 2019-04-17

该研究回顾性分析了2010至2014年间2387例因转移性脊髓压迫接受姑息性脊柱放疗的患者,其中220例接受了脊柱再照射。中位随访99天,14例出现再照射相关脊柱事件(6例放射性脊髓病,9例放射性椎体骨折),多因素分析显示糖尿病与毒性风险增加相关(HR=7.9,P=0.003)。

要点

  • 脊柱再照射后放射性脊髓病和放射性椎体骨折发生率低(220例中分别为6例和9例)。
  • 糖尿病与再照射后严重不良事件风险增加独立相关(HR=7.9,P=0.003)。
  • 脊柱再照射前应评估糖尿病状态以权衡风险。

核心结论

  • 脊柱再照射患者中放射性脊髓病和放射性椎体骨折发生率低。
  • 糖尿病患者再照射后发生严重不良事件的风险更高,再照射前应考虑此因素。

研究设计与样本

  • 回顾性队列研究,纳入2010至2014年某机构2387例因转移性脊髓压迫接受姑息性脊柱放疗的连续患者。
  • 其中220例有脊柱再照射史,从病历和放疗计划系统获取临床与治疗数据。

主要发现

  • 患者原发肿瘤为乳腺癌22.7%、前列腺癌21.8%、肺癌21.4%、血液系统肿瘤3.2%及其他30.9%。
  • 中位随访99天,中位累积EQD2为57.6 Gy2(范围20.0-90.0 Gy)。
  • 14例出现再照射相关脊柱事件:6例放射性脊髓病,9例放射性椎体骨折。
  • 多因素分析中糖尿病与毒性风险增加相关(HR=7.9;P=0.003)。

临床怎么用

  • 对计划接受脊柱再照射的患者,应评估糖尿病史以识别高危人群。
  • 再照射决策时需结合糖尿病状态权衡放射性脊髓病和椎体骨折风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In this study we investigate the risk of radiation-induced serious adverse event of the spine in a large cohort of consecutive retreated patients with palliative radiotherapy (RT) for metastatic cancer in the spine. METHODS AND MATERIALS: From 2010 to 2014, 2387 patients received spinal irradiation with a palliative intent for metastatic spinal cord compression at our institution. The patients were reviewed for prior RT and 220 patients had received re-irradiation of the spine. Clinical and treatment data were obtained from the patients' records and the RT planning system. RESULTS: Patients had metastatic disease from breast, prostate, lung, hematological or other cancers (22.7%, 21.8%, 21.4%, 3.2% and 30.9%, respectively). Median follow-up was 99 days. Median cumulative EQD2 was 57.6 Gy2; range: 20.0-90.0 Gy. Spinal events related to re-irradiation were observed in fourteen patients; six patients were diagnosed with radiation-induced myelopathy (RIM) and nine patients with radiation-induced vertebral fracture (RIF). In a multivariate analysis, diabetes was related to increased risk of toxicity (HR = 7.9; P = 0.003). CONCLUSION: The incidence of RIM and RIF (6 and 9 out of 220 patients, respectively) was low in our cohort of re-irradiated patients. Patients with diabetes had a higher risk of adverse events which should be considered before re-irradiation of the spine.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Suppli MH, Munck Af Rosenschöld P, Pappot H, et al. Diabetes increases the risk of serious adverse events after re-irradiation of the spine. Radiother Oncol. 2019. PMID: 31015114. doi:10.1016/j.radonc.2019.04.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。